1. Home
  2. TARS vs LKFN Comparison

TARS vs LKFN Comparison

Compare TARS & LKFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • LKFN
  • Stock Information
  • Founded
  • TARS 2016
  • LKFN 1872
  • Country
  • TARS United States
  • LKFN United States
  • Employees
  • TARS N/A
  • LKFN N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • LKFN Major Banks
  • Sector
  • TARS Health Care
  • LKFN Finance
  • Exchange
  • TARS Nasdaq
  • LKFN Nasdaq
  • Market Cap
  • TARS 1.7B
  • LKFN 1.7B
  • IPO Year
  • TARS 2020
  • LKFN 1997
  • Fundamental
  • Price
  • TARS $49.36
  • LKFN $65.02
  • Analyst Decision
  • TARS Strong Buy
  • LKFN Buy
  • Analyst Count
  • TARS 7
  • LKFN 2
  • Target Price
  • TARS $67.14
  • LKFN $68.00
  • AVG Volume (30 Days)
  • TARS 652.0K
  • LKFN 142.0K
  • Earning Date
  • TARS 11-12-2025
  • LKFN 10-24-2025
  • Dividend Yield
  • TARS N/A
  • LKFN 3.07%
  • EPS Growth
  • TARS N/A
  • LKFN N/A
  • EPS
  • TARS N/A
  • LKFN 3.67
  • Revenue
  • TARS $295,521,000.00
  • LKFN $239,375,000.00
  • Revenue This Year
  • TARS $33,170.29
  • LKFN $16.89
  • Revenue Next Year
  • TARS N/A
  • LKFN $4.98
  • P/E Ratio
  • TARS N/A
  • LKFN $17.73
  • Revenue Growth
  • TARS 254.45
  • LKFN N/A
  • 52 Week Low
  • TARS $30.23
  • LKFN $50.00
  • 52 Week High
  • TARS $59.76
  • LKFN $78.61
  • Technical
  • Relative Strength Index (RSI)
  • TARS 36.86
  • LKFN 46.50
  • Support Level
  • TARS $55.45
  • LKFN $66.02
  • Resistance Level
  • TARS $59.76
  • LKFN $68.40
  • Average True Range (ATR)
  • TARS 2.01
  • LKFN 1.81
  • MACD
  • TARS -1.34
  • LKFN -0.32
  • Stochastic Oscillator
  • TARS 8.77
  • LKFN 24.87

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

Share on Social Networks: